---
document_datetime: 2023-09-21 17:06:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_en.pdf
document_name: daliresp-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8588388
conversion_datetime: 2025-12-19 23:33:01.896615
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EMEA Number     | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging          |   Package size |
|-----------------|-----------------|------------|-----------------------|---------------------------|--------------------|----------------|
| EU/1/11/668/001 | Daliresp        | 500 µg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) |             10 |
| EU/1/11/668/002 | Daliresp        | 500 µg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) |             30 |
| EU/1/11/668/003 | Daliresp        | 500 µg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) |             90 |

<!-- image -->